Subscribe

 HCVets E-Alerts

Please Renew Your Information

Information:
Notice: Website under construction, contact Info@HCVets.com
 
Home
Test the Rest Campaign
Documentation & Surveillance Alerts
Military Hepatitis History  
Understanding The Liver 
VA Flow Sheet for Cirrhosis
VA Defines Risk Factors


Support Forums:
VA Claims
  

"Ask NOD"
What Would Veterans Do?
VA Claims Blog
Guidance for filing VA Claims

 
Firebase Network's Veterans Hour
with host Rick Townsend
Tune in Sunday
7:00~8:00 PM ET
09/16/2012
 
Info: ADD TO CLAIM!
Plan Backfires-
VBA Fast Letter Boost Claims
 
Legal- Service Connected Claims
# 1 CONCLUSION OF LAW 
# 2 CONCLUSION OF LAW 

More 

Jetgun Decisions
Hep C Decisions

 
Delphi Members Forum:

Visit Delphi On Line
One on One Support
Claim Advice

Health Concerns
VA Issues

 


Friend HCVets
 

Web Excellence Awarded


Click here to make HCVets your homepage


 

 

Scientists show brain vulnerable to Hepatitis C virus

January 18, 2012

(Medical Xpress) -- Scientists at the University of Birmingham have demonstrated for the first time that human brain cells can become infected with the Hepatitis C virus (HCV), it is reported today.

The team of virologists found that the endothelial cells in the brain possess the four main protein receptors necessary for the blood-brain barrier to be targeted by HCV.

The findings, which are published online today in Research Highlights in the journal Nature Reviews Gastroenterology and Hepatology, show that cells other than liver hepatocytes can be vulnerable to HCV infection.

Working with the Manhattan Brain Bank in New York, USA, the researchers, led by Dr Nicola Fletcher, of the University’s School of Immunity and Infection, detected HCV genomic materal in the brains of four of ten infected patients who posthumously donated brain and liver tissue.

The team went on to demonstrate in laboratory tests that brain cells isolated from the blood-brain barrier could be infected with HCV.

‘This is the first report that cells of the central nervous system support HCV replication,’ says corresponding author Professor Jane McKeating, chair of molecular virology at the University of Birmingham. ‘These observations could have clinical implications providing a reservoir for the virus to persist during anti-viral treatment’

"The endothelial cells make up the security system of the brain, a kind of bouncer at the door that keeps out undesirable elements," explains Dr Fletcher. "If this barrier is compromised all kinds of substances can gain access to the brain, which may explain the fatigue and other symptoms reported by HCV-infected patients."

The current standard of care for treating HCV-infected patients is only partially effective, she says, so there is a considerable drive to develop agents that target viral specific enzymes as alternative therapies.

"We anticipate that such agents will be less able to cross the blood-brain barrier compared to existing drugs. We believe our data provides a detailed mechanistic view of how an infectious agent can target the brain."

Hepatitis C virus (HCV) is an RNA virus of the Flaviviridae family that poses a global health problem. Infection leads to progressive liver disease and has been associated with a variety of extrahepatic syndromes, including central nervous system (CNS) abnormalities.


More information: Hepatitis C virus infects the endothelial cells of the blood-brain barrier (Gastroenterology, November 2011)


Provided by University of Birmingham
 

 

 

All data printed from this website is under scrutiny by Veterans Affairs Claims Process. It is called internet junk.... So it's important a copy is obtained from your local library and stamped as such to verify it's origin. References are provided for each source to obtain the copy.

For problems or questions regarding this Web site contact
Contact
 HCVets.com
Revised: May 05, 2012 .
 

FAIR USE NOTICE